Heart failure no longer death sentence for cancer survivors Dr. Kamal Kant Kohli1 Nov 2023 10:00 PM ISTCancer patients receiving anthracycline chemotherapy have more than twice the risk of developing heart failure compared to their peers without...
Obesity predisposes young adults to 17 types of cancers in later life Dr. Kamal Kant Kohli1 Nov 2023 4:30 AM ISTSweden: A recent study published in Obesity reports linear associations between body mass index (BMI) at age 18 and subsequent site-specific cancers....
Merck strengthens oncology pipeline through strategic partnership with Hengrui Ruchika Sharma31 Oct 2023 2:28 PM ISTGermany: Merck, a science and technology company, has announced a strategic collaboration with Jiangsu Hengrui Pharmaceuticals Co. Ltd. The...
Bristol Myers Squibb Opdivo in combo with cisplatin based chemotherapy gets EMA validation for Urothelial Carcinoma Ruchika Sharma31 Oct 2023 12:30 PM ISTPrinceton: Bristol Myers Squibb has announced that the European Medicines Agency (EMA) has validated its type II variation application for...
Phase III trial of Jemperli plus chemotherapy meets endpoint of overall survival in patients with primary advanced or recurrent endometrial cancer: GSK Ruchika Sharma31 Oct 2023 11:35 AM ISTLondon: GSK plc has announced positive headline results from a planned analysis of Part 1 of the RUBY/ENGOT-EN6/GOG3031/NSGO phase III trial...
Intas Pharma to commercialise Serplulimab in India Ruchika Sharma30 Oct 2023 3:29 PM ISTSerplulimab will be commercialised by Intas in India and by its subsidiary, Accord Healthcare Ltd, in Europe.
Innovative Therapy Boosts Natural Killer Cells to Fight Blood Cancers: Study Medha Baranwal29 Oct 2023 3:00 PM ISTUSA: Medical researchers at the University of Minnesota have developed an experimental method for treating hard-to-treat blood cancers using natural...
No casual link found between GLP-1 drugs like Novo Nordisk Ozempic, thyroid cancer: EMA Ruchika Sharma29 Oct 2023 12:30 PM ISTThe European Medicines Agency (EMA) has said its safety panel did not find a causal link between popular GLP-1 drugs such as Novo...
Venus Remedies gets market nod for Bleomycin 15000 IU in UK Ruchika Sharma29 Oct 2023 10:00 AM ISTMumbai: Venus Remedies has announced receipt of market authorization in the United Kingdom for Bleomycin 15,000 IU Powder for Solution for...
Anti-anxiety drug promising for improving survival in patients with most lethal brain cancer: Study Dr. Kamal Kant Kohli28 Oct 2023 9:00 AM ISTAustralia: A recent study showed that chemoradiation efficacy reduces in human cerebrospinal fluid (CSF) and suggests that a combination of...
GMC Rajouri gets dermatology wing to treat skin related cancer, diseases Kajal Rajput28 Oct 2023 7:45 AM ISTThe Medical Superintendent further added that 27 skin cancer cases like Basel Cell Carcinoma (BCC), Malignant Melanoma, Verrucous Carcinoma including...
Study explores link between diabetic complications and colorectal cancer Isra Zaman25 Oct 2023 9:30 AM ISTA recent study, published in the journal CANCER showed that patients with complicated diabetes face an 85% higher risk of early death from any cause...
